Uterine smooth muscle tumors of uncertain malignant potential (STUMP) are rare tumors with histologic features of both benign leiomyoma and leiomyosarcoma. Due to this, their clinical behavior is unpredictable, and long-term outcomes of progressing into malignant leiomyosarcoma should be closely investigated. We present the case of a 42-year-old woman diagnosed with STUMP following laparoscopic-assisted myomectomy. Despite total abdominal hysterectomy and negative initial follow-up, she developed metastatic leiomyosarcoma involving the thoracic spine and posterior chest wall within three years and expired due to multiorgan failure six years later. This case underscores the potential malignant behavior of STUMP and raises the question of the need for adjuvant therapy, such as chemotherapy, in selected high-risk patients’ post-hysterectomy.
Cite this paper
Chou, J. , Chou, S. and Chow, P. (2025). Malignant Progression of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP) to Metastatic Leiomyosarcoma: A Six-Year Case Evolution. Open Access Library Journal, 12, e14094. doi: http://dx.doi.org/10.4236/oalib.1114094.
Akad, F., Filip, B., Mocanu, V., Akad, M., Acatrinei, C. and Scripcariu, V. (2021) Rare Case of Smooth Muscle Tumor of Un-certain Malignant Potential—Clinical Case. Maedica, 16, 302-306.
Hsieh, J., Collins, S. and Morosky, C.M. (2012) Periurethral Smooth Muscle Tumor of Undetermined Malignant Potential. Case Reports in Obstetrics and Gynecology, 2012, Article ID: 546852. https://doi.org/10.1155/2012/546852
Dall’Asta, A., Gizzo, S., Musarò, A., Quaranta, M., Noventa, M., Migliavacca, C., Sozzi, G., Monica, M., Mautone, D. and Berretta, R. (2014) Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP): Pathology, Follow-Up and Recurrence. International Journal of Clinical and Exper-imental Pathology, 7, 8136-8141.
Oliva, E. (2016) Practical Issues in Uterine Pathology from Banal to Bewildering: The Remarkable Spectrum of Smooth Muscle Neoplasia. Modern Pathology, 29, S104-S120. https://doi.org/10.1038/modpathol.2015.139
Croce, S., Ribeiro, A., Hostein, I., Ferreira, C., MacGrogan, G., Velasco, V. and Chibon, F. (2022) Prognostic Value of Immunohistochemistry and Molecular Alterations in Uterine Smooth Muscle Tu-mors: A Comprehensive Review. Virchows Archiv, 480, 85-94.
Koc, N., Ozcan, T., Ureyen, I. and Turan, V. (2022) Recurrence and Clinical Outcomes in Patients with Uterine Smooth Muscle Tumors of Uncertain Malignant Potential. Ar-chives of Gynecology and Obstetrics, 306, 453-463.
Yordanova, V., Angelova, I., Mitev, D. and Dimitrova, I. (2023) Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP): Clinical Management and Long-term Follow-Up. Cancers (Basel), 15, Article 4373.
Thway, K. and Fisher, C. (2022) Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Histopathology, Differential Diagnosis and Predictive Markers. Histopathology, 80, 412-425.
Kaneko, R., Yoshida, A., Tsuta, K., et al. (2023) Genomic Landscape of Uterine Smooth Muscle Tumors: Insights into Progression from Stump to Leiomyosarcoma. Modern Pathology, 36, 2-5.
Ravegnini, G., Sammarini, G., Saponara, E., et al. (2021) Ge-nomic and Molecular Characterization of Uterine Smooth Muscle Tumors with Uncertain Malignant Potential. International Journal of Molecular Sciences, 22, 2-10.
Prat, J. and Mbatani, N. (2023) Uterine Sarcomas: Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. International Journal of Gynecology & Obstetrics, 160, 765-770.
Bucuri, C.E., et al. (2024) Smooth Muscle Tumor of Uncertain Malignant Potential: A Clinicopathologic Review and Obstetric Out-come. Canadian Journal of Pathology, 31, 388-391.
